Terumo enters consent decree with FDA banning sales of cardiac surgery devices to new customers
This article was originally published in Clinica
The US Department of Justice last Thursday (24 March) filed a consent decree between Terumo's US heart device unit and the FDA, which prohibits the company from manufacturing and distributing worldwide, to new customers, several of its products used during cardiac surgery, including two heart-lung bypass systems.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.